BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND MTCP1, C6_1B, 4515, ENSG00000214827, GS1-273L24_4 AND Prognosis
2292 results:

  • 1. Transcript and protein signatures derived from shared molecular interactions across cancers are associated with mortality.
    Zhao Y; Li X; Loscalzo J; Smelik M; Sysoev O; Wang Y; Mahmud AKMF; Mansour Aly D; Benson M
    J Transl Med; 2024 May; 22(1):444. PubMed ID: 38734658
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Prognostic factors and the role of primary debulking in operable stage IVB ovarian cancer with supraclavicular lymph node metastasis: a retrospective study in Chinese patients.
    Quan C; Chen X; Wen H; Wu X; Li J
    BMC Cancer; 2024 May; 24(1):565. PubMed ID: 38711015
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. piR-1919609 Is an Ideal Potential Target for Reversing Platinum Resistance in ovarian cancer.
    Yan Y; Tian D; Zhao B; Li Z; Huang Z; Li K; Chen X; Zhou L; Feng Y; Yang Z
    Technol Cancer Res Treat; 2024; 23():15330338241249692. PubMed ID: 38706262
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study.
    Kastellan S; Kalb R; Sajjad B; McReynolds LJ; Giri N; Samuel D; Milde T; Elbracht M; Holzhauer S; Niewisch MR; Kratz CP
    J Hematol Oncol; 2024 Apr; 17(1):26. PubMed ID: 38685107
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Exceptional lymph node recurrence of an unusual ovarian tumor 16 years later: a case report.
    Sakhri S; Slimane M; Bouaziz H; Khessairi N; Boujelbene N; Ben Dhiab T
    J Med Case Rep; 2024 Apr; 18(1):217. PubMed ID: 38654310
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Gonadoblastoma: Clinicopathological study and literature review of 3 cases].
    Bao ML; Li X; Chen G; Li H; Chen W; Li HX
    Zhonghua Nan Ke Xue; 2023 Jul; 29(7):634-638. PubMed ID: 38619412
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Development and validation of an ultrasound-based deep learning radiomics nomogram for predicting the malignant risk of ovarian tumours.
    Du Y; Xiao Y; Guo W; Yao J; Lan T; Li S; Wen H; Zhu W; He G; Zheng H; Chen H
    Biomed Eng Online; 2024 Apr; 23(1):41. PubMed ID: 38594729
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The splicing factor WBP11 mediates MCM7 intron retention to promote the malignant progression of ovarian cancer.
    Wei Y; Chen Z; Li Y; Song K
    Oncogene; 2024 May; 43(20):1565-1578. PubMed ID: 38561505
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Relationships of SIGLEC family-related lncRNAs with clinical prognosis and tumor immune microenvironment in ovarian cancer.
    Jin X; Chen Y; Hu Q
    Sci Rep; 2024 Mar; 14(1):7593. PubMed ID: 38556590
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Characteristics of patients with late recurrence endometrial cancer.
    Çakır İ; Gülseren V; Özdemir İA; Abacı H; Talu ECK; Çakır ZE; Ata C; Kuru O; Gökçü M; Sancı M; Güngördük K
    J Cancer Res Ther; 2024 Jan; 20(1):232-237. PubMed ID: 38554326
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Clinical analysis of 12 cases of ovarian yolk sac tumor].
    Liu J; Chu HJ; Shan YP; Song WJ; Chen AP
    Zhonghua Fu Chan Ke Za Zhi; 2024 Mar; 59(3):210-214. PubMed ID: 38544450
    [No Abstract]    [Full Text] [Related]  

  • 12. Review on the Role of BRCA Mutations in Genomic Screening and Risk Stratification of Prostate cancer.
    Kalampokis N; Zabaftis C; Spinos T; Karavitakis M; Leotsakos I; Katafigiotis I; van der Poel H; Grivas N; Mitropoulos D
    Curr Oncol; 2024 Feb; 31(3):1162-1169. PubMed ID: 38534919
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The analysis of preoperative or intraoperative factors in predicting the escalation of surgical pathological staging of patients with clinical stage I endometrioid carcinoma: A retrospective clinical study.
    Li N; Chen Q; Li B
    Medicine (Baltimore); 2024 Mar; 103(11):e37465. PubMed ID: 38489719
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Survival time prediction in patients with high-grade serous ovarian cancer based on
    He D; Zhang X; Chang Z; Liu Z; Li B
    BMC Cancer; 2024 Mar; 24(1):337. PubMed ID: 38475819
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A clinicopathological study about the epidemiology of granulosa cell tumors in Lebanon.
    Yaacoub S; Hajj L; Khairallah A
    BMC Cancer; 2024 Mar; 24(1):309. PubMed ID: 38448917
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The Role of Lymphovascular Space Invasion and Cytology in the prognosis of Endometrial cancer.
    Ozdemir CY; Arioz DT; Celik F; Cicekli N; Chkhikvadze M; Bilir F; Yılmaz S; Vatansever N
    Discov Med; 2024 Feb; 36(181):366-371. PubMed ID: 38409841
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. FoxO1 promotes ovarian cancer by increasing transcription and METTL14-mediated m
    Tan L; Wang S; Huang S; Tie Y; Sai N; Mao Y; Zhao S; Hou Y; Dou H
    Cancer Sci; 2024 Apr; 115(4):1224-1240. PubMed ID: 38403332
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The IGF-PAPP-A-Stanniocalcin Axis in Serum and Ascites Associates with prognosis in Patients with ovarian cancer.
    Hjortebjerg R; Høgdall C; Hansen KH; Høgdall E; Frystyk J
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396692
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Prevalence and spectrum of germline BRCA1 and BRCA2 in a cohort of ovarian cancer patients from the Salento peninsula (Southern Italy): a matter of preventive health.
    De Matteis E; Tumolo MR; Tarantino P; Ciccarese M; Grassi T; Bagordo F; De Giorgio MR; Rizzo E; Ronzino G
    Oncotarget; 2024 Feb; 15():134-141. PubMed ID: 38386807
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The significance of lower uterine segment involvement in endometrial cancer.
    Davidesko S; Meirovitz M; Shaco-Levy R; Yarza S; Samueli B; Kezerle Y; Kessous R
    Eur J Surg Oncol; 2024 Mar; 50(3):108007. PubMed ID: 38382274
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 115.